DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report to their offering.
Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022 provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report.
Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.
Key Topics Covered:
1 Preface
2 Research Methodology
3 Executive Summary
4 Introduction
5 Global Generic Drug Market
6 Global Generic Oncology Drug Market
7 Global Generic Drug Market: Performance of Key Regions
8 Global Generic Drug Market: Competitive Landscape
9 Generic Oncology Drug Manufacturing Process
10 Project Details, Requirements and Costs Involved
11 Loans and Financial Assistance
12 Project Economics
Companies Mentioned
- Freseunis
- Hospira
- Mylan
- Novartis
- Sandoz
For more information about this report visit http://www.researchandmarkets.com/research/j4zsjx/generic_oncology
